Understanding how bone cells communicate to improve bone health in older adults
A new model for spatio-temporal coupling of bone formation and bone resorption governed by osteoclasts
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10905262
This study is looking at how two important types of bone cells talk to each other to help keep our bones strong, and it aims to find new ways to prevent bone loss as we age, especially for those dealing with osteoporosis.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10905262 on ClinicalTrials.gov |
What this research studies
This research investigates the communication between two types of bone cells, osteoclasts and osteoblasts, which play crucial roles in bone formation and resorption. By exploring a newly discovered mechanism of cell communication called tunneling nanotubes, the study aims to identify how these cells interact and how this interaction can be manipulated to prevent bone loss associated with aging. The researchers will use live imaging techniques in animal models to observe these processes and test potential therapeutic solutions. This approach could lead to innovative treatments for osteoporosis, a condition that significantly affects older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing age-related bone loss or osteoporosis.
Not a fit: Patients who are younger and do not have any signs of bone loss or osteoporosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or reduce bone loss in older adults, thereby decreasing the risk of fractures.
How similar studies have performed: Previous research has shown promising results in understanding bone cell interactions, but this specific approach using tunneling nanotubes is relatively novel.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MISHINA, YUJI — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: MISHINA, YUJI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.